Chemotaxis of primitive hematopoietic cells in response to stromal cell- derived factor-1

Journal of Clinical Investigation

Volumn 105, Issue 1, 2000, Pages 101-111

  Jo, Deog Yeon ^a   Rafii, Shahin ^b   Hamada, Tsuneyoshi ^a   Moore, Malcolm A S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 3; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; THROMBOPOIETIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD; CELL CULTURE; CELL MIGRATION; CHEMOTAXIS; HEMATOPOIETIC CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STROMA CELL; UMBILICAL CORD BLOOD;

EID: 0033989027     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7954     Document Type: Article

References (45)

1. Hendrikx, P.J., Martens, A.C.M., Hagenbeek, A., Keij, J.F., and Visser, J.W.M. 1996. Homing of fluorescently labeled murine hematopoietic stem cells. Exp. Hematol. 24:129-140.
2. van der Loo, J.C.M., and Ploemacher, R.E. 1995. Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors. Blood. 85:2598-2606.
3. Papayannopoulou, T., and Craddock, C. 1997. Homing and trafficking of hemopoietic progenitor cells. Acta. Haematol. 97:97-104.
4. Papayannopoulou, T., and Nakamoto, B. 1993. Peripheralization of hematopoietic progenitors in primates treated with anti-VLA4 integrin. Proc. Natl. Acad. Sci. USA. 90:9374-9378.
5. Vermeulen, M., et al. 1998. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stein and progenitor cells. Blood. 92:894-900.
6. Nagasawa, T., Kikutani, H., and Kishimito, T. 1994. Molecular cloning and structure of a pre-B cell growth-stimulating factor. Proc. Natl. Acad. Sci. USA. 91:2305-2309.
7. Bleul, C.C., et al. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV entry. Nature. 382:829-832.
8. Bluel, C.C., Fuhlbrigge, R.C., Casanovas, J.M., Aiuti, A., and Springer, T.A. 1996. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184:1101-1109.
9. D'Apuzzo, M., et al. 1997. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur. J. Immunol. 27:1788-1793.
10. Aiuti, A., Webb, L.J., Bleul, C., Springer, T., and Gutierrez-Ramos, J.C. 1997. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 185:111-120.
11. Kim, C.H., and Broxmeyer, H.E. 1998. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood. 91:100-110.
12. Mohle, R., et al. 1998. The chemokine receptor CXCR4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell derived factor-1. Blood. 91:4523-4530.
13. Hamada, T., et al. 1998. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J. Exp. Med. 188:539-548.
14. Wang J.-F., Liu, Z.-Y., and Groopman, J.E. 1998. The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. Blood. 92:756-764.
15. Nagasawa, T., et al. 1996. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 382:635-638.
16. Tachibana, K., et al. 1998. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature. 393:591-594.
17. Zou, Y-R., Kottmann, A.H., Kuroda, M., Taniuchi, I, and Littman, D.R. 1998. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 393:595-599.
18. Sutherland, H.J., Eaves, C.J., Dragowska, W., and Lansdorp, P.M. 1989. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood. 74:1563-1580.
19. Breems, D.A., Blokland, E.A.W., Neben, S., and Ploemacher, R.E. 1994. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia. 8:1095-1104.
20. Wang, J.C.Y., Doedens, M., and Dick, J.E. 1997. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood. 89:3919-3924.
21. Noort, W.A., Willemze, R., and Falkenburg, J.H.F. 1998. Comparison of repopulating ability of hematopoietic progenitor cells isolated from human umbilical cord blood or bone marrow cells in NOD/SCID mice. Bone Marrow Transplant. 22(Suppl. 1):S58-S60.
22. Hogan, C.J., et al. 1997. Engraftment and development of human CD34+-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood. 90:85-96.
23. Hogan, C.J., Shpall, E.J., McNiece, I., and Keller, G. 1997. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells. Biol. Blood Marrow Transplant. 3:236-246.
24. Shimizu, Y., Ogawa, M., Kobayashi, M., Almeida-Porada, G., and Zanjani, E.D. 1998. Engraftment of cultured human hematopoietic cells in sheep. Blood. 91:3688-3692.
25. Gan, O.I., Murdoch, B., Larochelle, A., and Dick, J.E. 1997. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood. 90:641-650.
26. Mobest, D., et al. 1997. Kinetics of NOD/SCID mouse repopulating cells (SRC) diverge from colony-forming cells (CFC) and long-term culture-initiating cells (LTC-IC) during ex vivo expansion of CD34+ blood progenitor cells (PBC). Blood. 90(Suppl. 1):365. (Abstr.)
27. Brugger, W., Heimfeld, S., Berenson, R.J., Mertelsmann, R., and Kanz, L. 1995. Reconstitution of hematopoiesis after high dose chemotherapy by autologous progenitor cells generated ex vivo. N. Engl. J. Med. 333:283-287.
28. Holyoake, T.L., et al. 1997. CD34+ PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplant. 19:1095-1101.
29. Itoh, K., et al. 1989. Reproducible establishment of hemopoietic supportive cells lines from murine bone marrow. Exp. Hematol. 17:145-153.
30. Issad, C., Croisille, L., Katz, A, Vainchenker, W., and Coulombel, L. 1993. A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38-progenitor cells in long-term cultures and semi-solid assays. Blood. 81:2916-2924.
31. Rafii, S., et al. 1995. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood. 86:3353-3363.
32. Mohle, R., Moore, M.A.S., Nachman, R.L., and Rafii, S. 1997. Transendothelial migration of CD34+ and mature hematopoietic cells: a in vitro study using a human bone marrow endothelial cell line. Blood. 89:72-80.
33. Engelhardt, M., et al. 1997. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood. 90:182-193.
34. Gothot, A., van der Loo, J.C.M., Clapp, W., Srour E.F. 1998. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34+ cells in non-obese diabetic/severe combined immune-deficient mice. Blood. 92:2641-2649.
35. Ohmizono, Y., et al. 1997. Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand. Leukemia. 11:524-530.
36. Piacibello, W., et al. 1997. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 89:2644-2653.
37. Luens, K.M., et al. 1998. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin-cells with preserved ability to engraft SCID-hu bone. Blood. 91:1206-1215.
38. Peled, A., et al. 1999. Dependence of human stem cell engraftment and repopulation of NDO/SCID mice on CXCR4. Science. 283:845-848.
39. Spence, S.E., et al. 1998. Engraftment of ex vivo expanded and cycling human cord blood hematopoietic progenitor cells in SCID mice. Exp. Hematol. 26:507-514.
40. Shapiro, F., et al. 1994. Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer. Blood. 84:3567-3574.
41. Moore, M.A.S., and Hoskins, I. 1994. Ex vivo expansion of cord blood derived stem cells and progenitors. Blood Cells. 20:468-479.
42. Shapiro, F., et al. 1997. Effects of prior therapy on the in vitro proliferative potential of stem cell factor (SCF) plus Filgrastim-mobilized CD34+ progenitor cells. Clin. Cancer Res. 3:1571-1578.
43. Tavassoli, M., et al. 1991. Enhancement of the grafting efficiency of transplanted marrow cells by preincubation with interleukin-3 and granulocyte-macrophage colony-stimulating factor. Blood. 77:1599-1606.
44. Bhatia, M., et al. 1997. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J. Exp. Med. 186:619-624.
45. Conneally, E., Cashman, J., Petzer, A., and Eaves, C. 1997. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc. Natl. Acad. Sci. USA. 94:9836-9841.